Your browser doesn't support javascript.
loading
Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants.
Li, Kan; Huntwork, Richard H C; Horn, Gillian Q; Abraha, Milite; Hastie, Kathryn M; Li, Haoyang; Rayaprolu, Vamseedhar; Olmedillas, Eduardo; Feeney, Elizabeth; Cronin, Kenneth; Schendel, Sharon L; Heise, Mark; Bedinger, Daniel; Mattocks, Melissa D; Baric, Ralph S; Alam, S Munir; Ollmann Saphire, Erica; Tomaras, Georgia D; Dennison, S Moses.
  • Li K; Center for Human Systems Immunology, Duke University, Durham, North Carolina, USA.
  • Huntwork RHC; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Horn GQ; Center for Human Systems Immunology, Duke University, Durham, North Carolina, USA.
  • Abraha M; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Hastie KM; Center for Human Systems Immunology, Duke University, Durham, North Carolina, USA.
  • Li H; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Rayaprolu V; Center for Human Systems Immunology, Duke University, Durham, North Carolina, USA.
  • Olmedillas E; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Feeney E; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Cronin K; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Schendel SL; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Heise M; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Bedinger D; Center for Human Systems Immunology, Duke University, Durham, North Carolina, USA.
  • Mattocks MD; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Baric RS; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
  • Alam SM; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Ollmann Saphire E; Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Tomaras GD; Carterra Inc., Salt Lake City, Utah, USA.
  • Dennison SM; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, USA.
J Virol ; 97(12): e0107023, 2023 Dec 21.
Article en En | MEDLINE | ID: mdl-38019013
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Glicoproteína de la Espiga del Coronavirus / SARS-CoV-2 / Anticuerpos Antivirales Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Glicoproteína de la Espiga del Coronavirus / SARS-CoV-2 / Anticuerpos Antivirales Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article